BioXcel Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
BioXcel Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2019 to Q1 2024.
  • BioXcel Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $3.61M, a 7.13% increase year-over-year.
  • BioXcel Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $13.6M, a 17.1% increase year-over-year.
  • BioXcel Therapeutics, Inc. annual Interest Expense for 2023 was $13.3M, a 62.1% increase from 2022.
  • BioXcel Therapeutics, Inc. annual Interest Expense for 2022 was $8.21M, a 20433% increase from 2021.
  • BioXcel Therapeutics, Inc. annual Interest Expense for 2021 was $40K, a 48.1% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.6M $3.61M +$240K +7.13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $13.3M $3.44M +$516K +17.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 $12.8M $3.25M -$448K -12.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $13.2M $3.26M +$1.67M +105% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $11.6M $3.37M +$3.36M +48000% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $8.21M $2.92M +$2.91M +48567% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $5.3M $3.7M +$3.69M +33536% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.61M $1.59M +$1.57M +9813% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $40K $7K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $40K $6K +$2K +50% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $38K $11K +$6K +120% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $32K $16K +$4K +33.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $28K $7K +$1K +16.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $27K $4K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $5K -$13K -72.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $12K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $6K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 $18K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.